To view this email as a web page, click here

 
logo fierce Pharma logo logo
 
 

Dear E,

 

We value your membership in the Fierce Life Sciences community and would like to inform you of our domain and IP address change. To ensure you keep getting information from Fierce Biotech and Fierce Pharma delivered, follow these 2 simple steps:

  1. Add us to your address book: editors@go.fiercebiotech.com, editors@go.fiercepharma.com and events@go.fiercelifesciences.com
  2. Whitelist our email sending domains: go.fiercebiotech.com and go.fiercepharma.com and our IP addresses: 205.162.46.93 and 205.162.46.101
    • Whitelisting is a way to tell your email provider that you want to receive our emails, here are some easy instructions on doing this.
    • If you are receiving this email at a corporate email address, let your IT team know you’d like them to whitelist go.fiercebiotech.com, go.fiercepharma.com and go.fiercelifesciences.com.

We are excited to continue connecting with you through industry news, trends, events and data. Thanks for being a part of the Fierce Life Sciences community!


Sincerely,

Rebecca Willumson
Publisher
Fierce Biotech & Fierce Pharma
rwillumson@questex.com

 
 


 
 

Your privacy and security is important to us. We will never ask you for password information or personal details in our emails. Moving forward, only open emails from us from the domains: go.fiercebiotech.com, go.fiercepharma.com and go.fiercelifesciences.com.

 
 
 
 
 

 

 

To unsubscribe from future communications from Fierce Life Sciences, please click here: click here

Refer to our Privacy Policy

 

Fierce Life Sciences  is a division of Questex LLC.
685 Third Ave, 21st Floor, New York, NY 10017

© 2021 Questex LLC. All Rights Reserved.
Reproduction in whole or in part is prohibited without written permission.